Literature DB >> 14206613

A SUGGESTED CONTROL GENE MECHANISM FOR THE EXCESSIVE PRODUCTION OF TYPES I AND 3 PORPHYRINS IN CONGENITAL ERYTHROPOIETIC PORPHYRIA.

C J WATSON, W RUNGE, L TADDEINI, I BOSSENMAIER, R CARDINAL.   

Abstract

Keywords:  AMINOHYDROLASES; BONE MARROW CELLS; BONE MARROW EXAMINATION; CATTLE DISEASES; ERYTHROCYTES; ISOMERASES; MUTATION; PORPHYRIA; UROBILINOGEN

Mesh:

Substances:

Year:  1964        PMID: 14206613      PMCID: PMC300302          DOI: 10.1073/pnas.52.2.478

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  31 in total

1.  delta-aminolaevulate dehydratase from Rhodopseudomonas spheroides.

Authors:  B F BURNHAM; W S PIERCE; K R WILLIAMS; M H BOYER; C K KIRBY
Journal:  Biochem J       Date:  1963-06       Impact factor: 3.857

2.  ERYTHROPOIETIC PROTOPORPHYRIA. A NEW TYPE OF INBORN ERROR OF METABOLISM.

Authors:  B HAEGER-ARONSEN
Journal:  Am J Med       Date:  1963-10       Impact factor: 4.965

3.  Erythropoietic (congenital) porphyria: A rare abnormality of the normoblasts.

Authors:  R SCHMID; S SCHWARTZ; R D SUNDBERG
Journal:  Blood       Date:  1955-05       Impact factor: 22.113

4.  A qualitative and quantitative study of the separation of uroporphyrin octamethyl esters I and III by dioxan chromatography.

Authors:  P A CORNFORD; A BENSON
Journal:  J Chromatogr       Date:  1963-02

5.  Genetic regulatory mechanisms in the synthesis of proteins.

Authors:  F JACOB; J MONOD
Journal:  J Mol Biol       Date:  1961-06       Impact factor: 5.469

6.  A metabolic myopathy due to absence of muscle phosphorylase.

Authors:  C M PEARSON; D G RIMER; W F MOMMAERTS
Journal:  Am J Med       Date:  1961-04       Impact factor: 4.965

7.  Erythropoietic protoporphyria. A new porphyria syndrome with solar urticaria due to protoporphyrinaemia.

Authors:  I A MAGNUS; A JARRETT; T A PRANKERD; C RIMINGTON
Journal:  Lancet       Date:  1961-08-26       Impact factor: 79.321

8.  Porphyrin content of bone marrow and liver in the various forms of porphyria.

Authors:  R SCHMID; S SCHWARTZ; C J WATSON
Journal:  AMA Arch Intern Med       Date:  1954-02

9.  The manifestations of the different forms of porphyria in relation to chemical findings.

Authors:  C J WATSON; P T LOWRY; R SCHMID; V E HAWKINSON; S SCHWARTZ
Journal:  Trans Assoc Am Physicians       Date:  1951

10.  Photosensitive or congenital porphyria with hemolytic anemia. II. Isotopic studies of porphyrin and hemoglobin metabolism.

Authors:  M GRINSTEIN; R A ALDRICH; V HAWKINSON; P LOWRY; C J WATSON
Journal:  Blood       Date:  1951-08       Impact factor: 22.113

View more
  14 in total

1.  ACUTE INTERMITTENT PORPHYRIA: THE FIRST "OVERPRODUCTION DISEASE" LOCALIZED TO A SPECIFIC ENZYME.

Authors:  D P TSCHUDY; M G PERLROTH; H S MARVER; A COLLINS; G HUNTER; M RECHCIGL
Journal:  Proc Natl Acad Sci U S A       Date:  1965-04       Impact factor: 11.205

Review 2.  The porphyrias: a review.

Authors:  G H Elder; C H Gray; D C Nicholson
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

3.  [Enzyme determination in erythrocytes of patients with porphyria cutanea tarda].

Authors:  H Holzmann; R Denk; B Morsches
Journal:  Klin Wochenschr       Date:  1969-01-15

Review 4.  [Genetic aspects of metabolic disorders].

Authors:  W Fuhrmann
Journal:  Klin Wochenschr       Date:  1971-05

5.  Uroporphyrinogen 3 cosynthetase in asymptomatic carriers of congenital erythpoietic porphyria.

Authors:  G Romeo; B L Glenn; E Y Levin
Journal:  Biochem Genet       Date:  1970-12       Impact factor: 1.890

6.  Hepatic porphyrias.

Authors: 
Journal:  Br Med J       Date:  1971-05-01

7.  Erythropoietic porphyria of the fox squirrel Sciurus niger.

Authors:  E Y Levin; V Flyger
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

8.  Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria.

Authors:  C J Watson; I Bossenmaier; R Cardinal; Z J Petryka
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

Review 9.  Enzymatic defects of hereditary porphyrias: an explanation of dominance at the molecular level.

Authors:  G Romeo
Journal:  Hum Genet       Date:  1977-12-23       Impact factor: 4.132

10.  Presynaptic neuromuscular inhibition by porphobilinogen and porphobilin.

Authors:  D S Feldman; R D Levere; J S Lieberman; R A Cardinal; C J Watson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.